619 related articles for article (PubMed ID: 26564244)
21. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
22. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
[TBL] [Abstract][Full Text] [Related]
23. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
25. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
Li X; Zhang M; Wang B; Li Y; Wang L; Zhao X; Zhou X; Guo Y; Jiang G; Yao C
J Ethnopharmacol; 2013 Dec; 150(3):907-17. PubMed ID: 24140602
[TBL] [Abstract][Full Text] [Related]
26. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
[TBL] [Abstract][Full Text] [Related]
28. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
29. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
30. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.
Chen CA; Chung WC; Chiou YY; Yang YJ; Lin YC; Ochs HD; Shieh CC
J Microbiol Immunol Infect; 2016 Oct; 49(5):775-782. PubMed ID: 26748735
[TBL] [Abstract][Full Text] [Related]
32. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
Li J; Wang Z; Hu S; Zhao X; Cao L
Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
[TBL] [Abstract][Full Text] [Related]
33. The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance.
Lin ZW; Wu LX; Xie Y; Ou X; Tian PK; Liu XP; Min J; Wang J; Chen RF; Chen YJ; Liu C; Ye H; Ou QJ
Int J Med Sci; 2015; 12(1):7-16. PubMed ID: 25552913
[TBL] [Abstract][Full Text] [Related]
34. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.
Martin M; Kesselring RK; Saidou B; Brunner SM; Schiechl G; Mouris VF; Wege AK; Rümmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Eur J Immunol; 2015 Jun; 45(6):1667-79. PubMed ID: 25820779
[TBL] [Abstract][Full Text] [Related]
35. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
[TBL] [Abstract][Full Text] [Related]
36. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
37. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
38. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
39. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
40. Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.
Parodi A; Traverso P; Kalli F; Conteduca G; Tardito S; Curto M; Grillo F; Mastracci L; Bernardi C; Nasi G; Minaglia F; Simonato A; Carmignani G; Ferrera F; Fenoglio D; Filaci G
Oncotarget; 2016 Feb; 7(6):6424-35. PubMed ID: 26824503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]